Galena Biopharma to Present at the 14th Annual BIO CEO & Investor Conference
February 07 2012 - 7:05AM
Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on
developing innovative, targeted oncology treatments addressing
major unmet medical needs to advance cancer care, today announced
that Mark J. Ahn, Ph.D., President and Chief Executive Officer,
will present a corporate update at the 14th Annual BIO CEO &
Investor Conference. The presentation will take place on Monday,
February 13th, 2012 at 2:30 PM EST at the Waldorf Astoria Hotel,
New York, NY.
The presentation will be webcast and available on the Investors
section of the Company's website at www.galenabiopharma.com.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted
oncology treatments that address major unmet medical needs to
advance cancer care. For more information please visit us at
www.galenabiopharma.com.
The Galena Biopharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton
Toll free: +1 (855) 855-GALE (4253), ext. 109
info@galenabiopharma.com
or
Remy Bernarda
IR Sense, LLC
+1 (503) 400-6995
remy@irsense.com
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2024 to May 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From May 2023 to May 2024